STOCKS IN ACTION 7 February

UPL: Moody's Investors Service downgraded the company's senior unsecured rating to 'Ba1' from
'Baa3' on deterioration in the agrochemical industry fundamentals.

JB Chemicals & Pharmaceuticals: The company appointed Narayan Saraf as chief financial officer effective Feb. 23.

Biocon: The company received USFDA tentative approval for Dasatinib tablets, which are used in the treatment of the Philadelphia chromosome.

Lupin: The company received USFDA approval from ANDA for bromfenac ophthalmic solution, which is a generic of bromsite.

Power Finance Corp: The company incorporated Bhadla-III and Bikaner-Ill transmission as a wholly owned subsidiary for the development of transmission system strengthening for interconnections of the Bhadla Ill and Bikaner-ll complexes.

Yasho Industries: The company begins a trial run at the Bharuch unit for manufacturing industrial chemicals.

Karnataka Bank: The company received an RBI nod for exercising the call option on bonds.

Mahindra Lifespace Developers: The company received an Irdai nod for a Rs 1,612 crore capital infusion by Axis Bank, subject to CCI approval.

Mahindra Life: The company received a Rs 2.3 crore penalty for non-adherence to forest norms.

Tata Motors: tops Titan in M-cap to regain second most valuable group company tag

MaxLife: Gets IRDAI approval for capital infusion of up to ₹1,612 crore by Axis Bank in the company, subject to the approval of CCI

SBILifeInsurance: buys shares of Krishna Institute of Medical Sciences for Rs 239 crore through an open market transaction.

@daytradertelugu